FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:906 March 31, 1994 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Figure 1

View larger version (41K): [in this window] [in a new window]   Figure 1. Herpes Zoster. A 78-year-old man had numerous crusts and erosions on the right side of his face and scalp. Staining with a monoclonal-antibody stain (Syva Microtrak, Palo Alto, Calif.) conjugated with fluorescein isothiocyanate specific for varicella-zoster virus glycoproteins was performed on fluid from lesions on the patient's back and was positive. An ophthalmologic examination also revealed keratitis. The only risk factor identified for dissemination was the daily use of 1 percent hydrocortisone cream when the facial lesions first appeared. The patient was treated with intravenous acyclovir along with trifluridine and sulfacetamide-prednisolone eye drops. After the lesions disappeared, postherpetic . . . [Full Text of this Article]

 

Related Letters:

Trifluridine for Herpes Zoster
Harris D. J., Rosencrance G., Frances C.
Extract | Full Text  
N Engl J Med 1994; 331:481-482, Aug 18, 1994. Correspondence

This article has been cited by other articles:

• Harris, D. J., Rosencrance, G., Frances, C. (1994). Trifluridine for Herpes Zoster. NEJM 331: 481-482 [Full Text]